Automation index

How much of a Olive-oil miller’s job can AI already do?

A yield comes earlier. Cold extracting without overheating do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

22%

AI can already do 22% of this job.

#357 / 653

Olive-oil miller

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Intake, yield and the mill log. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Crush, malaxate and the decanter. Estimate No public source provides a precise figure. This is our estimate.	18%	12%	+2.2
Temperature, time and the fruitiness. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Cellar, the batch and the one that goes rancid. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
The campaign, the tractor queue and not heating. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Cold for real, and not painting the yield. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		22%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#168 / 653

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low